US equities |
MU $989.04 ▲+0.00% SNDK $1,487.33 ▲+0.00% META $742.96 ▲+0.00% NVDA $226.32 ▲+0.00% SKHY $162.23 ▲+0.00% GS $893.95 ▲+0.00% UNH $378.52 ▲+0.00% JPM $334.30 ▲+0.00%
FinancialContent

Latest News about KETARX

Recent news which mentions KETARX

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
Tickers FTHWF PHRRF
Tags Markets Asset Sales PHRRF
From Benzinga
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
Tickers PHRRF
Tags Markets Psychedelics Cannabis
From Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
Tickers PHRRF
Tags Fabio Chianelli Benzinga PHRRF
From Benzinga
PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment
Tickers PHRRF
Tags Psychedelics KETARX Cannabis
From Benzinga